In addition to tumor hypoxia, downregulation of antioxidant systems in breast cancer cells further potentiates ROS production through the loss of SIRT-3 function induced by the accumulation of mROS and the stabilization of HIF-1α [58]. This evidence concerns the gene HIF1A and breast cancer.